Preoperative blood markers for prediction of recurrence-free survival after surgical treatment of patients with stage III lung adenocarcinoma.

Tahanovich, A D; Kauhanka, N N; Murashka, D I; Kolb, A V; Prokhorova, V I; Got'ko, O V; Derzhavets, L A

Tahanovich, A D; Kauhanka, N N; Murashka, D I; Kolb, A V; Prokhorova, V I; Got'ko, O V; Derzhavets, L A.

Tahanovich AD; Belarusian State Medical University.
Kauhanka NN; Belarusian State Medical University.
Murashka DI; Belarusian State Medical University.
Kolb AV; Belarusian State Medical University.
Prokhorova VI; National Centre of oncology and medical radiology.
Got'ko OV; National Centre of oncology and medical radiology.
Derzhavets LA; National Centre of oncology and medical radiology.

Klin Lab Diagn ; 67(11): 640-646, 2022 Nov 14.

Article en En | MEDLINE | ID: mdl-36398772

Asunto(s)

Adenocarcinoma del Pulmón; Neoplasias Pulmonares; Humanos; Neoplasias Pulmonares/cirugía; Neoplasias Pulmonares/patología; Biomarcadores de Tumor; Recurrencia Local de Neoplasia; Adenocarcinoma del Pulmón/cirugía

Palabras clave

CXCR1; CYFRA 21-1; blood cells; lung adenocarcinoma; prognosis; relapse

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google